ID   5HT2C_RAT               Reviewed;         460 AA.
AC   P08909;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   02-OCT-2024, entry version 179.
DE   RecName: Full=5-hydroxytryptamine receptor 2C {ECO:0000305};
DE            Short=5-HT-2C;
DE            Short=5-HT2C;
DE            Short=5-HTR2C;
DE   AltName: Full=5-hydroxytryptamine receptor 1C;
DE            Short=5-HT-1C;
DE            Short=5-HT1C;
DE   AltName: Full=Serotonin receptor 2C;
DE   Flags: Precursor;
GN   Name=Htr2c {ECO:0000312|RGD:2848}; Synonyms=5ht1c, Htr1c;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=3399891; DOI=10.1126/science.3399891;
RA   Julius D., McDermott A.B., Axel R., Jessell T.M.;
RT   "Molecular characterization of a functional cDNA encoding the serotonin 1c
RT   receptor.";
RL   Science 241:558-564(1988).
RN   [2]
RP   INTERACTION WITH MPDZ, AND MUTAGENESIS OF SER-458 AND SER-459.
RX   PubMed=12682077; DOI=10.1074/jbc.m210973200;
RA   Parker L.L., Backstrom J.R., Sanders-Bush E., Shieh B.H.;
RT   "Agonist-induced phosphorylation of the serotonin 5-HT2C receptor regulates
RT   its interaction with multiple PDZ protein 1.";
RL   J. Biol. Chem. 278:21576-21583(2003).
CC   -!- FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine
CC       (serotonin) (PubMed:3399891). Also functions as a receptor for various
CC       drugs and psychoactive substances, including ergot alkaloid
CC       derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and
CC       lysergic acid diethylamide (LSD) (By similarity). Ligand binding causes
CC       a conformation change that triggers signaling via guanine nucleotide-
CC       binding proteins (G proteins) and modulates the activity of downstream
CC       effectors (By similarity). HTR2C is coupled to G(q)/G(11) G alpha
CC       proteins and activates phospholipase C-beta, releasing diacylglycerol
CC       (DAG) and inositol 1,4,5-trisphosphate (IP3) second messengers that
CC       modulate the activity of phosphatidylinositol 3-kinase and promote the
CC       release of Ca(2+) ions from intracellular stores, respectively (By
CC       similarity). Beta-arrestin family members inhibit signaling via G
CC       proteins and mediate activation of alternative signaling pathways (By
CC       similarity). Regulates neuronal activity via the activation of short
CC       transient receptor potential calcium channels in the brain, and thereby
CC       modulates the activation of pro-opiomelanocortin neurons and the
CC       release of CRH that then regulates the release of corticosterone (By
CC       similarity). Plays a role in the regulation of appetite and eating
CC       behavior, responses to anxiogenic stimuli and stress (By similarity).
CC       Plays a role in insulin sensitivity and glucose homeostasis (By
CC       similarity). {ECO:0000250|UniProtKB:P28335,
CC       ECO:0000250|UniProtKB:P34968, ECO:0000269|PubMed:3399891}.
CC   -!- SUBUNIT: Interacts with MPDZ (PubMed:12682077). Interacts with ARRB2
CC       (By similarity). Interacts with MPP3; this interaction stabilizes the
CC       receptor at the plasma membrane and prevents the desensitization of the
CC       HTR2C receptor-mediated calcium response (By similarity).
CC       {ECO:0000250|UniProtKB:P28335, ECO:0000269|PubMed:12682077}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:3399891};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: The PDZ domain-binding motif is involved in the interaction
CC       with MPDZ. {ECO:0000250|UniProtKB:P28335}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M21410; AAA42177.1; -; Genomic_DNA.
DR   PIR; A32605; A32605.
DR   RefSeq; NP_036897.2; NM_012765.3.
DR   PDB; 2MHO; NMR; -; B=452-460.
DR   PDBsum; 2MHO; -.
DR   AlphaFoldDB; P08909; -.
DR   BMRB; P08909; -.
DR   SMR; P08909; -.
DR   IntAct; P08909; 1.
DR   MINT; P08909; -.
DR   STRING; 10116.ENSRNOP00000070471; -.
DR   BindingDB; P08909; -.
DR   ChEMBL; CHEMBL324; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00935; Oxymetazoline.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugCentral; P08909; -.
DR   GuidetoPHARMACOLOGY; 8; -.
DR   GlyCosmos; P08909; 3 sites, No reported glycans.
DR   GlyGen; P08909; 3 sites.
DR   iPTMnet; P08909; -.
DR   PhosphoSitePlus; P08909; -.
DR   PaxDb; 10116-ENSRNOP00000060345; -.
DR   Ensembl; ENSRNOT00000065293.3; ENSRNOP00000060345.3; ENSRNOG00000030877.6.
DR   Ensembl; ENSRNOT00055041874; ENSRNOP00055034111; ENSRNOG00055024346.
DR   Ensembl; ENSRNOT00060031522; ENSRNOP00060025592; ENSRNOG00060018315.
DR   Ensembl; ENSRNOT00065015758; ENSRNOP00065011925; ENSRNOG00065009778.
DR   GeneID; 25187; -.
DR   KEGG; rno:25187; -.
DR   AGR; RGD:2848; -.
DR   CTD; 3358; -.
DR   RGD; 2848; Htr2c.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00940000161671; -.
DR   InParanoid; P08909; -.
DR   OrthoDB; 2880253at2759; -.
DR   PhylomeDB; P08909; -.
DR   Reactome; R-RNO-390666; Serotonin receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   EvolutionaryTrace; P08909; -.
DR   PRO; PR:P08909; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0098666; C:G protein-coupled serotonin receptor complex; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; ISO:RGD.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IMP:RGD.
DR   GO; GO:0001587; F:Gq/11-coupled serotonin receptor activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0051378; F:serotonin binding; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0001662; P:behavioral fear response; ISS:UniProtKB.
DR   GO; GO:0035095; P:behavioral response to nicotine; IMP:RGD.
DR   GO; GO:0019934; P:cGMP-mediated signaling; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007631; P:feeding behavior; IMP:RGD.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0098664; P:G protein-coupled serotonin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; IEA:InterPro.
DR   GO; GO:0045963; P:negative regulation of dopamine metabolic process; IMP:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007208; P:phospholipase C-activating serotonin receptor signaling pathway; IDA:RGD.
DR   GO; GO:0031583; P:phospholipase D-activating G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0014057; P:positive regulation of acetylcholine secretion, neurotransmission; IMP:RGD.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISO:RGD.
DR   GO; GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IMP:RGD.
DR   GO; GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; ISO:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0032098; P:regulation of appetite; ISS:UniProtKB.
DR   GO; GO:0043397; P:regulation of corticotropin-releasing hormone secretion; ISS:UniProtKB.
DR   GO; GO:0031644; P:regulation of nervous system process; ISS:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IMP:RGD.
DR   GO; GO:0046960; P:sensitization; IMP:RGD.
DR   GO; GO:0007210; P:serotonin receptor signaling pathway; IBA:GO_Central.
DR   CDD; cd15305; 7tmA_5-HT2C; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000377; 5HT2C_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24247; 5-HYDROXYTRYPTAMINE RECEPTOR; 1.
DR   PANTHER; PTHR24247:SF32; 5-HYDROXYTRYPTAMINE RECEPTOR 2C; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00517; 5HT2CRECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Behavior; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   CHAIN           33..460
FT                   /note="5-hydroxytryptamine receptor 2C"
FT                   /id="PRO_0000068961"
FT   TOPO_DOM        33..56
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        57..81
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        82..87
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        88..112
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        113..129
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        130..152
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        153..168
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        169..190
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        191..214
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        215..237
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        238..313
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        314..338
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        339..349
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TRANSMEM        350..372
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   TOPO_DOM        373..460
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   REGION          276..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           152..154
FT                   /note="DRY motif; important for ligand-induced conformation
FT                   changes"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           366..370
FT                   /note="NPxxY motif; important for ligand-induced
FT                   conformation changes and signaling"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           458..460
FT                   /note="PDZ-binding"
FT   BINDING         140
FT                   /ligand="ergotamine"
FT                   /ligand_id="ChEBI:CHEBI:190463"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   BINDING         210
FT                   /ligand="ergotamine"
FT                   /ligand_id="ChEBI:CHEBI:190463"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:P28335"
FT   CARBOHYD        204
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        205
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        128..208
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        339..343
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   MUTAGEN         458
FT                   /note="S->A,D: Loss of interaction with MPDZ."
FT                   /evidence="ECO:0000269|PubMed:12682077"
FT   MUTAGEN         459
FT                   /note="S->D: No effect on interaction with MPDZ."
FT                   /evidence="ECO:0000269|PubMed:12682077"
SQ   SEQUENCE   460 AA;  51917 MW;  D44E977D8F80047E CRC64;
     MVNLGNAVRS LLMHLIGLLV WQFDISISPV AAIVTDTFNS SDGGRLFQFP DGVQNWPALS
     IVVIIIMTIG GNILVIMAVS MEKKLHNATN YFLMSLAIAD MLVGLLVMPL SLLAILYDYV
     WPLPRYLCPV WISLDVLFST ASIMHLCAIS LDRYVAIRNP IEHSRFNSRT KAIMKIAIVW
     AISIGVSVPI PVIGLRDESK VFVNNTTCVL NDPNFVLIGS FVAFFIPLTI MVITYFLTIY
     VLRRQTLMLL RGHTEEELAN MSLNFLNCCC KKNGGEEENA PNPNPDQKPR RKKKEKRPRG
     TMQAINNEKK ASKVLGIVFF VFLIMWCPFF ITNILSVLCG KACNQKLMEK LLNVFVWIGY
     VCSGINPLVY TLFNKIYRRA FSKYLRCDYK PDKKPPVRQI PRVAATALSG RELNVNIYRH
     TNERVARKAN DPEPGIEMQV ENLELPVNPS NVVSERISSV
//
